Injectable “Skin Boosters” in Aging Skin Rejuvenation: A Current Overview

Abstract

Aging-related changes in the skin, such as dullness, dehydration, and loss of elasticity, significantly affect its appearance and integrity. Injectable “skin boosters,” comprising various biological materials, have become increasingly prominent in addressing these issues, offering rejuvenation and revitalization. This review offers a comprehensive examination of these injectables, detailing their types, mechanisms of action, and clinical uses. It also evaluates the evidence for their effectiveness and safety in treating age-related skin alterations and other conditions. The goal is to provide an insightful understanding of injectable skin boosters in contemporary dermatological practice, summarizing the current state of knowledge.

Keywords

amino acid - botulinum neurotoxin - collagen - hyaluronic acid - intradermal injection - needle-free jet injector - poly-(lactic acid) - polycaprolactone - polydeoxyribonucleotide - skin booster

Authors' Contributions

Conceptualization, N.-K.R., W.L.. Writing, N.-K.R.; Review, editing and supervision. H.-S. K., S.-Y. K., N.-K. R. All authors have read and agreed to the published version of the manuscript.

Ethical Approval

Since it is a review article, ethical approval was not required for this article.

Patient Consent

Not applicable.

Publication History

Received: 07 January 2024

Accepted: 21 April 2024

Accepted Manuscript online:
16 July 2024

Article published online:
13 November 2024

• References

• 1 Di Gregorio C, DʼArpa S. Therapeutic use of hyaluronic acid fillers in the treatment of corticosteroid-induced skin and subcutaneous atrophy. Dermatol Surg 2016; 42 (11) 1307-1310
• 2 Reuther T, Bayrhammer J, Kerscher M. Effects of a three-session skin rejuvenation treatment using stabilized hyaluronic acid-based gel of non-animal origin on skin elasticity: a pilot study. Arch Dermatol Res 2010; 302 (01) 37-45
• 3 Deglesne PA, Arroyo R, Ranneva E, Deprez P. In vitro study of RRS HA injectable mesotherapy/biorevitalization product on human skin fibroblasts and its clinical utilization. Clin Cosmet Investig Dermatol 2016; 9: 41-53
• 4 Ypiranga S, Fonseca R. Hyaluronic acid filler for skin booster on the face. In: Issa MCA, Tamura B. eds. Botulinum Toxins, Fillers and Related Substances. New York: Springer Link; 2017: 1-10
• 5 Kerscher M, Bayrhammer J, Reuther T. Rejuvenating influence of a stabilized hyaluronic acid-based gel of nonanimal origin on facial skin aging. Dermatol Surg 2008; 34 (05) 720-726
• 6 Nikolis A, Enright KM. Evaluating the role of small particle hyaluronic acid fillers using micro-droplet technique in the face, neck and hands: a retrospective chart review. Clin Cosmet Investig Dermatol 2018; 11: 467-475
• 7 Bertucci V, Lynde CB. Current concepts in the use of small-particle hyaluronic acid. Plast Reconstr Surg 2015; 136 (5 Suppl): 132S-138S
• 8 Wang F, Garza LA, Kang S. et al. In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin. Arch Dermatol 2007; 143 (02) 155-163
• 9 Turley EA, Noble PW, Bourguignon LYW. Signaling properties of hyaluronan receptors. J Biol Chem 2002; 277 (07) 4589-4592
• 10 Landau M, Fagien S. Science of hyaluronic acid beyond filling: fibroblasts and their response to the extracellular matrix. Plast Reconstr Surg 2015; 136 (5 Suppl): 188S-195S
• 11 Mast BA, Diegelmann RF, Krummel TM, Cohen IK. Hyaluronic acid modulates proliferation, collagen and protein synthesis of cultured fetal fibroblasts. Matrix 1993; 13 (06) 441-446
• 12 Belmontesi M, De Angelis F, Di Gregorio C. et al. Injectable non-animal stabilized hyaluronic acid as a skin quality booster: an expert panel consensus. J Drugs Dermatol 2018; 17 (01) 83-88
• 13 Arora G, Arora S, Sadoughifar R, Batra N. Biorevitalization of the skin with skin boosters: concepts, variables, and limitations. J Cosmet Dermatol 2021; 20 (08) 2458-2462
• 14 Micheels P, Sarazin D, Besse S, Sundaram H, Flynn TC. A blanching technique for intradermal injection of the hyaluronic acid Belotero. Plast Reconstr Surg 2013; 132 (4 Suppl 2): 59S-68S
• 15 Kim J. Effects of injection depth and volume of stabilized hyaluronic acid in human dermis on skin texture, hydration, and thickness. Arch Aesthetic Plast Surg 2014; 20: 97-103
• 16 Ayatollahi A, Firooz A, Samadi A. Evaluation of safety and efficacy of booster injections of hyaluronic acid in improving the facial skin quality. J Cosmet Dermatol 2020; 19 (09) 2267-2272
• 17 Vedamurthy M, Duvvuru V, Chelikani VL. Skin boosters—the upcoming boom in cosmetic dermatology for healthy skin. Cosmoderma. May 29, 2023;3:82. Accessed at: https://cosmoderma.org/skin-boosters-the-upcoming-boom-in-cosmetic-dermatology-for-healthy-skin/
• 18 Baek A, Kim M, Kim SH, Cho SR, Kim HJ. Anti-inflammatory effect of DNA polymeric molecules in a cell model of osteoarthritis. Inflammation 2018; 41 (02) 677-688
• 19 Rho NK, Han KH, Cho M, Kim HS. A survey on the cosmetic use of injectable polynucleotide: the pattern of practice among Korean Dermatologists. J Cosmet Dermatol 2024; 23 (04) 1243-1252
• 20 Park J, Park HJ, Rho MC, Joo J. Viscosupplementation in the therapy for osteoarthritic knee. Appl Sci (Basel) 2021; 11: 11621
• 21 Khan A, Wang G, Zhou F. et al. Polydeoxyribonucleotide: a promising skin anti-aging agent. Chin J Plast Reconstr Surg 2022; 4: 187-193
• 22 Squadrito F, Bitto A, Irrera N. et al. Pharmacological activity and clinical use of PDRN. Front Pharmacol 2017; 8: 224
• 23 Park KY, Seok J, Rho NK, Kim BJ, Kim MN. Long-chain polynucleotide filler for skin rejuvenation: efficacy and complications in five patients. Dermatol Ther 2016; 29 (01) 37-40
• 24 Araco A, Araco F. Preliminary prospective and randomized study of highly purified polynucleotide vs placebo in treatment of moderate to severe acne scars. Aesthet Surg J 2021; 41 (07) NP866-NP874
• 25 Belmontesi M. Polydeoxyribonucleotide for the improvement of a hypertrophic retracting scar–an interesting case report. J Cosmet Dermatol 2020; 19 (11) 2982-2986
• 26 Yoon S, Kang JJ, Kim J, Park S, Kim JM. Efficacy and safety of intra-articular injections of hyaluronic acid combined with polydeoxyribonucleotide in the treatment of knee osteoarthritis. Ann Rehabil Med 2019; 43 (02) 204-214
• 27 Lee D, Kim MJ, Park HJ. et al. Current practices and perceived effectiveness of polynucleotides for treatment of facial erythema by cosmetic physicians. Skin Res Technol 2023; 29 (09) e13466
• 28 Pak CS, Lee J, Lee H. et al. A phase III, randomized, double-blind, matched-pairs, active-controlled clinical trial and preclinical animal study to compare the durability, efficacy and safety between polynucleotide filler and hyaluronic acid filler in the correction of crow's feet: a new concept of regenerative filler. J Korean Med Sci 2014; 29 (Suppl. 03) S201-S209
• 29 Lee YJ, Kim HT, Lee YJ. et al. Comparison of the effects of polynucleotide and hyaluronic acid fillers on periocular rejuvenation: a randomized, double-blind, split-face trial. J Dermatolog Treat 2022; 33 (01) 254-260
• 30 Kim JH, Kim ES, Kim SW, Hong SP, Kim J. Effects of polynucleotide dermal filler in the correction of crow's feet using an Antera three-dimensional camera. Aesthetic Plast Surg 2022; 46 (04) 1902-1909
• 31 Colangelo MT, Vicedomini ML, Belletti S, Govoni P, Guizzardi S, Galli C. A biomimetic polynucleotides–hyaluronic acid hydrogel promotes the growth of 3d spheroid cultures of gingival fibroblasts. Appl Sci (Basel) 2023; 13: 743
• 32 Segreto F, Carotti S, Marangi GF. et al. The use of acellular porcine dermis, hyaluronic acid and polynucleotides in the treatment of cutaneous ulcers: single blind randomised clinical trial. Int Wound J 2020; 17 (06) 1702-1708
• 33 Cavallini M, Bartoletti E, Maioli L. et al; As Members of The Polynucleotides HPT™ Priming Board, Collegio Italiano delle Società Scientifiche di Medicina Estetica (Italian College of the Aesthetic Medicine Scientific Societies) - SIME, AGORÀ, SIES. Consensus report on the use of PN-HPT™ (polynucleotides highly purified technology) in aesthetic medicine. J Cosmet Dermatol 2021; 20 (03) 922-928
• 34 Friess W. Collagen–biomaterial for drug delivery. Eur J Pharm Biopharm 1998; 45 (02) 113-136
• 35 Yang C, Hillas PJ, Báez JA. et al. The application of recombinant human collagen in tissue engineering. BioDrugs 2004; 18 (02) 103-119
• 36 Ochiya T, Takahama Y, Nagahara S. et al. New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet. Nat Med 1999; 5 (06) 707-710
• 37 Ochiya T, Nagahara S, Sano A, Itoh H, Terada M. Biomaterials for gene delivery: atelocollagen-mediated controlled release of molecular medicines. Curr Gene Ther 2001; 1 (01) 31-52
• 38 Cheema U, Ananta M, Muder V. Collagen: applications of a natural polymer in regenerative medicine. In: Eberli D. ed. Regenerative Medicine and Tissue Engineering – Cells and Biomaterials. InTech; 2011: 287-300
• 39 Jariwala N, Ozols M, Bell M. et al. Matrikines as mediators of tissue remodelling. Adv Drug Deliv Rev 2022; 185: 114240
• 40 Tedesco M, Bellei B, Garelli V. et al. Adipose tissue stromal vascular fraction and adipose tissue stromal vascular fraction plus platelet-rich plasma grafting: New regenerative perspectives in genital lichen sclerosus. Dermatol Ther 2020; 33 (06) e14277
• 41 Gentile P, Orlandi A, Scioli MG. et al. A comparative translational study: the combined use of enhanced stromal vascular fraction and platelet-rich plasma improves fat grafting maintenance in breast reconstruction. Stem Cells Transl Med 2012; 1 (04) 341-351
• 42 Han X, Ji D, Liu Y, Hu S. Efficacy and safety of transplantation of autologous fat, platelet-rich plasma (PRP) and stromal vascular fraction (SVF) in the treatment of acne scar: systematic review and meta-analysis. Aesthetic Plast Surg 2023; 47 (04) 1623-1632
• 43 Stevens HP, Donners S, de Bruijn J. Introducing platelet-rich stroma: platelet-rich plasma (PRP) and stromal vascular fraction (SVF) combined for the treatment of androgenetic alopecia. Aesthet Surg J 2018; 38 (08) 811-822
• 44 Rigotti G, Charles-de-Sá L, Gontijo-de-Amorim NF. et al. Expanded stem cells, stromal-vascular fraction, and platelet-rich plasma enriched fat: comparing results of different facial rejuvenation approaches in a clinical trial. Aesthet Surg J 2016; 36 (03) 261-270
• 45 Gentile P, Scioli MG, Bielli A, Orlandi A, Cervelli V. Concise review: the use of adipose-derived stromal vascular fraction cells and platelet rich plasma in regenerative plastic surgery. Stem Cells 2017; 35 (01) 117-134
• 46 Shin SH, Lee YH, Rho NK, Park KY. Skin aging from mechanisms to interventions: focusing on dermal aging. Front Physiol 2023; 14: 1195272
• 47 Haddad S, Galadari H, Patil A, Goldust M, Al Salam S, Guida S. Evaluation of the biostimulatory effects and the level of neocollagenesis of dermal fillers: a review. Int J Dermatol 2022; 61 (10) 1284-1288
• 48 Kim JH, Kwon TR, Lee SE. et al. Comparative evaluation of the effectiveness of novel hyaluronic acid-polynucleotide complex dermal filler. Sci Rep 2020; 10 (01) 5127
• 49 Oh H, Lee S, Na J, Kim JH. Comparative evaluation of safety and efficacy of a novel hyaluronic acid-polynucleotide/poly-L-lactic acid composite dermal filler. Aesthetic Plast Surg 2021; 45 (04) 1792-1801
• 50 Elango J, Zamora-Ledezma C, Maté-Sánchez de Val JE. Natural vs synthetic polymers: how do they communicate with cells for skin regeneration—a review. J Compos Sci 2023; 7: 385
• 51 Capuana E, Lopresti F, Ceraulo M, La Carrubba V. Poly-L-lactic acid (PLLA)-based biomaterials for regenerative medicine: a review on processing and applications. Polymers (Basel) 2022; 14 (06) 1153
• 52 Lam SM, Azizzadeh B, Graivier M. Injectable poly-L-lactic acid (Sculptra): technical considerations in soft-tissue contouring. Plast Reconstr Surg 2006; 118 (3 Suppl) 55S-63S
• 53 Lin JY, Fu JP, Hsu NJ, Lin CY. Early-stage volume effect difference between injectable poly-l-lactic acid and injectable poly-d,l-lactic acid. J Cosmet Dermatol 2023; 22 (05) 1702-1703
• 54 Casabona G, Alfertshofer M, Kaye K. et al. Ex vivo product distribution of injectable biostimulator substances. Aesthet Surg J 2023; 43 (05) NP348-NP356
• 55 Lafaurie M, Dolivo M, Porcher R, Rudant J, Madelaine I, Molina JM. Treatment of facial lipoatrophy with intradermal injections of polylactic acid in HIV-infected patients. J Acquir Immune Defic Syndr 2005; 38 (04) 393-398
• 56 Moyle GJ, Lysakova L, Brown S. et al. A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med 2004; 5 (02) 82-87
• 57 Palm M, Mayoral F, Rajani A. et al. Chart review presenting safety of injectable PLLA used with alternative reconstitution volume for facial treatments. J Drugs Dermatol 2021; 20 (01) 118-122
• 58 Oh S, Seo SB, Kim G, Batsukh S, Son KH, Byun K. Poly-D,L-lactic acid stimulates angiogenesis and collagen synthesis in aged animal skin. Int J Mol Sci 2023; 24 (09) 7986
• 59 Oh S, Lee JH, Kim HM. et al. Poly-L-lactic acid fillers improved dermal collagen synthesis by modulating M2 macrophage polarization in aged animal skin. Cells 2023; 12 (09) 1320
• 60 Lin CY, Pervykh S, Lysikova V, Markova N, Lin JY. Two-fold serial dilution: a simple method to adjust thickness of injectable poly-D,L-lactic acid. Plast Reconstr Surg Glob Open 2021; 9 (08) e3753
• 61 Hong EH, Baek EJ, Suh SB, Kim KH. The role of sonication in preparing injectable poly-l-lactic acid. J Cosmet Dermatol 2022; 21 (05) 1973-1978
• 62 An MK, Hong EH, Suh SB, Park EJ, Kim KH. Combination therapy of microneedle fractional radiofrequency and topical poly-lactic acid for acne scars: a randomized controlled split-face study. Dermatol Surg 2020; 46 (06) 796-802
• 63 Hyeong JH, Jung JW, Seo SB, Kim HS, Kim KH. Intradermal injection of poly-D,L-lactic acid using microneedle fractional radiofrequency for acne scars: an open-label prospective trial. Dermatol Surg 2022; 48 (12) 1306-1311
• 64 Roberts SAI, Arthurs BP. Severe visual loss and orbital infarction following periorbital aesthetic poly-(L)-lactic acid (PLLA) injection. Ophthal Plast Reconstr Surg 2012; 28 (03) e68-e70
• 65 Wang I, Lin HJ, Tsai YY. et al. Multiple branch retinal artery occlusions following the new facial cosmetic filler (poly-D, L-lactic acid) injection a case report. BMC Ophthalmol 2023; 23 (01) 86
• 66 Raina N, Pahwa R, Khosla JK, Gupta PN, Gupta M. Polycaprolactone-based materials in wound healing applications. Polym Bull 2022; 79: 7041-7063
• 67 Kim JS. Changes in dermal thickness in biopsy study of histologic findings after a single injection of polycaprolactone-based filler into the dermis. Aesthet Surg J 2019; 39 (12) NP484-NP494
• 68 Kim J. Isovolemic degradation of polycaprolactone particles and calculation of their original size from human biopsy. Plast Reconstr Surg Glob Open 2020; 8 (06) e2866
• 69 Christen MO, Vercesi F. Polycaprolactone: how a well-known and futuristic polymer has become an innovative collagen-stimulator in esthetics. Clin Cosmet Investig Dermatol 2020; 13: 31-48
• 70 Yanatma I, Sarac G, Gul M, Gul S, Kapicioglu Y. Comparison of polycaprolactone and calcium hydroxylapatite dermal fillers in a rat model. Dermatol Ther 2021; 34 (01) e14716
• 71 Hong JY, Kim JH, Kwon TR, Hong JK, Li K, Kim BJ. In vivo evaluation of novel particle-free polycaprolactone fillers for safety, degradation, and neocollagenesis in a rat model. Dermatol Ther 2021; 34 (02) e14770
• 72 Laeschke K. Biocompatibility of microparticles into soft tissue fillers. Semin Cutan Med Surg 2004; 23 (04) 214-217
• 73 Fei Y, Huang Q, Hu Z, Yang X, Yang B, Liu S. Biomimetic cerium oxide loaded gelatin PCL nanosystems for wound dressing on cutaneous care management of multidrug-resistant bacterial wound healing. J Cluster Sci 2021; 32: 1289-1298
• 74 Lin SL, Christen MO. Polycaprolactone-based dermal filler complications: a retrospective study of 1111 treatments. J Cosmet Dermatol 2020; 19 (08) 1907-1914
• 75 Moon SY, Eun DH, Park JH. et al. Foreign body reaction three years after injection with polycaprolactone (Ellanse^®). Eur J Dermatol 2017; 27 (05) 549-551
• 76 Skrzypek E, Górnicka B, Skrzypek DM, Krzysztof MR. Granuloma as a complication of polycaprolactone-based dermal filler injection: ultrasound and histopathology studies. J Cosmet Laser Ther 2019; 21 (02) 65-68
• 77 Kwon TR, Han SW, Yeo IK. et al. Biostimulatory effects of polydioxanone, poly-d, l lactic acid, and polycaprolactone fillers in mouse model. J Cosmet Dermatol 2019; 18 (04) 1002-1008
• 78 Casalini T, Perale G. Types of bioresorbable polymers for medical applications. In: Jenkins M, Stamboulis A. eds. Durability and Reliability of Medical Polymers. Amsterdam: Elsevier; 2012: 3-29
• 79 Zhou SY, Kang SM, Gu YJ. et al. Bio-characteristics and efficacy analysis of biodegradable poly dioxanone dermal filler in a mouse model and humans. In Vivo 2023; 37 (03) 1093-1102
• 80 Kim CM, Kim BY, Hye Suh D, Lee SJ, Moon HR, Ryu HJ. The efficacy of powdered polydioxanone in terms of collagen production compared with poly-L-lactic acid in a murine model. J Cosmet Dermatol 2019; 18 (06) 1893-1898
• 81 Seo SB, Park H, Jo JY, Ryu HJ. Skin rejuvenation effect of the combined PDLLA and non cross-linked hyaluronic acid: a preliminary study. J Cosmet Dermatol 2024; 23 (03) 794-802
• 82 Nowag B, Schäfer D, Hengl T, Corduff N, Goldie K. Biostimulating fillers and induction of inflammatory pathways: a preclinical investigation of macrophage response to calcium hydroxylapatite and poly-L lactic acid. J Cosmet Dermatol 2024; 23 (01) 99-106
• 83 Oh S, Seo SB, Kim G. et al. Poly-D,L-lactic acid filler increases extracellular matrix by modulating macrophages and adipose-derived stem cells in aged animal skin. Antioxidants 2023; 12 (06) 1204
• 84 Kleine-Börger L, Hofmann M, Kerscher M. Microinjections with hyaluronic acid in combination with glycerol: How do they influence biophysical viscoelastic skin properties?. Skin Res Technol 2022; 28 (04) 633-642
• 85 Kerscher M, Prager W, Fischer TC. et al. Facial skin revitalization with Cohesive Polydensified Matrix-HA20G: results from a randomized multicenter clinical study. Plast Reconstr Surg Glob Open 2021; 9 (12) e3973
• 86 Hertz-Kleptow D, Hanschmann A, Hofmann M, Reuther T, Kerscher M. Facial skin revitalization with CPM^®-HA20G: an effective and safe early intervention treatment. Clin Cosmet Investig Dermatol 2019; 12: 563-572
• 87 de Wit A, Siebenga PS, Wijdeveld RW, Koopmans PC, van Loghem JAJ. A split-face comparative performance evaluation of injectable hyaluronic acid-based preparations HCC and CPM-HA20G in healthy females. J Cosmet Dermatol 2022; 21 (11) 5576-5583
• 88 Hara M, Verkman AS. Glycerol replacement corrects defective skin hydration, elasticity, and barrier function in aquaporin-3-deficient mice. Proc Natl Acad Sci U S A 2003; 100 (12) 7360-7365
• 89 Boury-Jamot M, Sougrat R, Tailhardat M. et al. Expression and function of aquaporins in human skin: Is aquaporin-3 just a glycerol transporter?. Biochim Biophys Acta 2006; 1758 (08) 1034-1042
• 90 Frank MSB, Nahata MC, Hilty MD. Glycerol: a review of its pharmacology, pharmacokinetics, adverse reactions, and clinical use. Pharmacotherapy 1981; 1 (02) 147-160
• 91 Stella E, Goisis M. Neck and décolleté. In: Goisis M. ed. Injections in Aesthetic Medicine. Milano: Springer Milan; 2014: 145-154
• 92 Dioguardi FS. Nutrition and skin. Collagen integrity: a dominant role for amino acids. Clin Dermatol 2008; 26 (06) 636-640
• 93 Di Petrillo A, Goisis M. The neck. In: Goisis M. ed. Outpatient Regenerative Medicine. New York: Springer International Publishing; 2019: 223-236
• 94 Scarano A, Sbarbati A, Amore R. et al. The role of hyaluronic acid and amino acid against the aging of the human skin: a clinical and histological study. J Cosmet Dermatol 2021; 20 (07) 2296-2304
• 95 Sparavigna A, Tenconi B. Efficacy and tolerance of an injectable medical device containing hyaluronic acid and amino acids: a monocentric six-month open-label evaluation. Clin Cosmet Investig Dermatol 2016; 9: 297-305
• 96 Iorizzo M, De Padova MP, Tosti A. Biorejuvenation: theory and practice. Clin Dermatol 2008; 26 (02) 177-181
• 97 Robin S, Fanian F, Courderot-Masuyer C. et al. Efficacy of a biorevitalizing-filler solution on all skin aspects: 10 years approach through in vitro studies and clinical trials. J Cosmetics Dermatol Sci Appl 2021; 11: 18-37
• 98 Jäger C, Brenner C, Habicht J, Wallich R. Bioactive reagents used in mesotherapy for skin rejuvenation in vivo induce diverse physiological processes in human skin fibroblasts in vitro- a pilot study. Exp Dermatol 2012; 21 (01) 72-75
• 99 Savoia A, Landi S, Baldi A. A new minimally invasive mesotherapy technique for facial rejuvenation. Dermatol Ther (Heidelb) 2013; 3 (01) 83-93
• 100 Byun KA, Oh S, Batsukh S. et al. The extracellular matrix vitalizer RATM increased skin elasticity by modulating mitochondrial function in aged animal skin. Antioxidants 2023; 12 (03) 694
• 101 Prikhnenko S. Polycomponent mesotherapy formulations for the treatment of skin aging and improvement of skin quality. Clin Cosmet Investig Dermatol 2015; 8: 151-157
• 102 Fabi SG, Park JY, Goldie K, Wu W. Microtoxin for improving pore size, skin laxity, sebum control, and scars: a roundtable on integrating intradermal botulinum toxin type a microdoses into clinical practice. Aesthet Surg J 2023; 43 (09) 1015-1024
• 103 Gazerani P, Pedersen NS, Drewes AM, Arendt-Nielsen L. Botulinum toxin type A reduces histamine-induced itch and vasomotor responses in human skin. Br J Dermatol 2009; 161 (04) 737-745
• 104 Zhu J, Ji X, Xu Y. et al. The efficacy of intradermal injection of type A botulinum toxin for facial rejuvenation. Dermatol Ther 2017; 30 (01) e12433
• 105 Dubina M, Tung R, Bolotin D. et al. Treatment of forehead/glabellar rhytide complex with combination botulinum toxin a and hyaluronic acid versus botulinum toxin A injection alone: a split-face, rater-blinded, randomized control trial. J Cosmet Dermatol 2013; 12 (04) 261-266
• 106 Sparavigna A, Bombelli L, Giori AM, Bellia G. Efficacy and tolerability of hybrid complexes of high- and low-molecular-weight hyaluronan intradermal injections for the treatment of skin roughness and laxity of the neck. ScientificWorldJournal 2022; 2022: 4497176
• 107 Noormohammadpour P, Ehsani A, Mahmoudi H. et al. Botulinum toxin injection as a single or combined treatment with non-cross-linked high molecular weight and low molecular weight hyaluronic acid gel for neck rejuvenation: a randomized clinical trial. Dermatol Ther 2022; 35 (10) e15673
• 108 Jeon H, Kim T, Kim H, Cho SB. Multimodal approach for treating horizontal neck wrinkles using intensity focused ultrasound, cohesive polydensified matrix hyaluronic acid, and IncobotulinumtoxinA. Dermatol Surg 2018; 44 (03) 421-431
• 109 Pisal PH. The combined effect of botulinum toxin type a with a biorevitalizing treatment on forehead rejuvenation: a case series. J Cosmetics Dermatol Sci Appl 2023; 13: 124-135
• 110 Kenner JR. Hyaluronic acid filler and botulinum Neurotoxin delivered simultaneously in the same syringe for effective and convenient combination aesthetic rejuvenation therapy. J Drugs Dermatol 2010; 9 (09) 1135-1138
• 111 Kim J. Clinical effects on skin texture and hydration of the face using microbotox and microhyaluronicacid. Plast Reconstr Surg Glob Open 2018; 6 (11) e1935
• 112 Cohen JL, Mariwall K. Combining fillers and neuromodulators in the same syringe. J Drugs Dermatol 2013; 12 (09) 976
• 113 Lallow EO, Busha KJ, Park SH. et al. Molecular distribution in intradermal injection for transfer and delivery of therapeutics. Front Drug Deliv 2023; 3: 1095181
• 114 Choi SY, Ko EJ, Yoo KH, Han HS, Kim BJ. Effects of hyaluronic acid injected using the mesogun injector with stamp-type microneedle on skin hydration. Dermatol Ther 2020; 33 (06) e13963
• 115 Srinivas CR, Somani A, Shashidharan Nair CK, Mylswamy T. Spring-loaded syringe for multiple rapid injections. J Cutan Aesthet Surg 2017; 10 (01) 49-50
• 116 Seok J, Oh CT, Kwon HJ. et al. Investigating skin penetration depth and shape following needle-free injection at different pressures: a cadaveric study. Lasers Surg Med 2016; 48 (06) 624-628
• 117 Han HS, Kim BR, Kim M. et al. Needleless laser injector versus needle injection for skin enhancement and rejuvenation effect of dermal filler. Lasers Surg Med 2023; 55 (09) 809-816
• 118 Rohilla P, Marston J. Feasibility of laser induced jets in needle free jet injections. Int J Pharm 2020; 589: 119714
• 119 Schoppink J, Fernandez Rivas D. Jet injectors: perspectives for small volume delivery with lasers. Adv Drug Deliv Rev 2022; 182: 114109
• 120 Taberner A, Hogan NC, Hunter IW. Needle-free jet injection using real-time controlled linear Lorentz-force actuators. Med Eng Phys 2012; 34 (09) 1228-1235
• 121 Wu YC, Lin KH, Shen YC, Wei LC. Sudden visual loss following cosmetic poly-(L)-lactic acid injection into the forehead: a case report. J Clin Exp Ophthalmol 2019; 10: 809
• 122 Stewart DB, Morganroth GS, Mooney MA, Cohen J, Levin PS, Gladstone HB. Management of visible granulomas following periorbital injection of poly-L-lactic Acid. Ophthal Plast Reconstr Surg 2007; 23 (04) 298-301
• 123 Goldman MP. Cosmetic use of poly-L-lactic acid: my technique for success and minimizing complications. Dermatol Surg 2011; 37 (05) 688-693
• 124 Li A, Long A, Fang R, Mao X, Sun Q. High-frequency ultrasound for long-term safety assessment of poly-L-lactic acid facial filler. Dermatol Surg 2022; 48 (10) 1071-1075
• 125 Soltani-Arabshahi R, Wong JW, Duffy KL, Powell DL. Facial allergic granulomatous reaction and systemic hypersensitivity associated with microneedle therapy for skin rejuvenation. JAMA Dermatol 2014; 150 (01) 68-72